Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.

ABSTRACT:

SUBMITTER: Chen AM 

PROVIDER: S-EPMC2833276 | biostudies-literature | 2009 Dec

REPOSITORIES: biostudies-literature